Literature DB >> 16187332

Expression of common chromosomal fragile site genes, WWOX/FRA16D and FHIT/FRA3B is downregulated by exposure to environmental carcinogens, UV, and BPDE but not by IR.

Elangovan Thavathiru1, John H Ludes-Meyers, Michael C MacLeod, C Marcelo Aldaz.   

Abstract

Common chromosomal fragile sites are unstable genomic loci susceptible to breakage, rearrangement, and are highly recombinogenic. Frequent alterations at these loci in tumor cells led to the hypothesis that they may contribute to cancer development. The two most common chromosomal fragile sites FRA16D and FRA3B which harbor WWOX and FHIT genes, respectively, are frequently altered in human cancers. Here we report that environmental carcinogens, ultraviolet (UV) light, and Benzo[a]pyrene diol epoxide (BPDE), significantly downregulate expression of both genes. On the other hand, we observe that ionizing radiation (IR) does not affect expression of these genes, suggesting that the effect of repression exerted by UV and BPDE is not just a consequence of DNA damage but may be a result of different signaling pathways triggered by specific DNA lesions. Such downregulation correlates with an induction of an S-phase delay in the cell cycle. Treatment of UV-irradiated cells with caffeine abrogates the S-phase delay while concomitantly overcoming the repression phenomenon. This suggests the involvement of unique cell cycle checkpoint mechanisms in the observed repression. Therefore, it is hypothesized that protracted downregulation of the putative tumor suppressor genes WWOX and FHIT by environmental carcinogens may constitute an additional mechanism of relevance in the initiation of tumorigenesis. Copyright 2005 Wiley-Liss, Inc

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16187332      PMCID: PMC4166602          DOI: 10.1002/mc.20122

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  65 in total

1.  Functional genomics of UV radiation responses in human cells.

Authors:  Christine A Koch-Paiz; Sally A Amundson; Michael L Bittner; Paul S Meltzer; Albert J Fornace
Journal:  Mutat Res       Date:  2004-05-18       Impact factor: 2.433

2.  Unique patterns of gene expression changes in liver after treatment of mice for 2 weeks with different known carcinogens and non-carcinogens.

Authors:  Mari Iida; Colleen H Anna; Wanda M Holliday; Jennifer B Collins; Michael L Cunningham; Robert C Sills; Theodora R Devereux
Journal:  Carcinogenesis       Date:  2004-12-23       Impact factor: 4.944

Review 3.  FHIT in human cancer.

Authors:  G Sozzi; K Huebner; C M Croce
Journal:  Adv Cancer Res       Date:  1998       Impact factor: 6.242

Review 4.  Distribution and repair of photolesions in DNA: genetic consequences and the role of sequence context.

Authors:  E Sage
Journal:  Photochem Photobiol       Date:  1993-01       Impact factor: 3.421

5.  WWOX: a candidate tumor suppressor gene involved in multiple tumor types.

Authors:  A J Paige; K J Taylor; C Taylor; S G Hillier; S Farrington; D Scott; D J Porteous; J F Smyth; H Gabra; J E Watson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

6.  WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer.

Authors:  A K Bednarek; K J Laflin; R L Daniel; Q Liao; K A Hawkins; C M Aldaz
Journal:  Cancer Res       Date:  2000-04-15       Impact factor: 12.701

7.  A novel approach for analyzing the structure of DNA modified by Benzo[a]pyrene diol epoxide at single-molecule resolution.

Authors:  L I Pietrasanta; B L Smith; M C MacLeod
Journal:  Chem Res Toxicol       Date:  2000-05       Impact factor: 3.739

8.  WW domain containing oxidoreductase gene expression is altered in non-small cell lung cancer.

Authors:  Sai Yendamuri; Tamotsu Kuroki; Francesco Trapasso; Adam C Henry; Kristoffel R Dumon; Kay Huebner; Noel N Williams; Larry R Kaiser; Carlo M Croce
Journal:  Cancer Res       Date:  2003-02-15       Impact factor: 12.701

9.  DNA polymerase alpha inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes.

Authors:  T W Glover; C Berger; J Coyle; B Echo
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

10.  Wild-type p53 is a cell cycle checkpoint determinant following irradiation.

Authors:  S J Kuerbitz; B S Plunkett; W V Walsh; M B Kastan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

View more
  20 in total

1.  Loss of lung WWOX expression causes neutrophilic inflammation.

Authors:  Sunit Singla; Jiwang Chen; Shruthi Sethuraman; Justin R Sysol; Amulya Gampa; Shuangping Zhao; Roberto F Machado
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-03-10       Impact factor: 5.464

Review 2.  WWOX gene and gene product: tumor suppression through specific protein interactions.

Authors:  Zaidoun Salah; Rami Aqeilan; Kay Huebner
Journal:  Future Oncol       Date:  2010-02       Impact factor: 3.404

3.  WWOX, the common fragile site FRA16D gene product, regulates ATM activation and the DNA damage response.

Authors:  Mohammad Abu-Odeh; Zaidoun Salah; Christoph Herbel; Thomas G Hofmann; Rami I Aqeilan
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-20       Impact factor: 11.205

Review 4.  Role of WW domain proteins WWOX in development, prognosis, and treatment response of glioma.

Authors:  Shin-Yi Liu; Ming-Fu Chiang; Yu-Jen Chen
Journal:  Exp Biol Med (Maywood)       Date:  2014-11-27

Review 5.  WWOX, large common fragile site genes, and cancer.

Authors:  Ge Gao; David I Smith
Journal:  Exp Biol Med (Maywood)       Date:  2015-01-16

6.  Fhit loss in lung preneoplasia: relation to DNA damage response checkpoint activation.

Authors:  Roberto Cirombella; Giuseppe Montrone; Antonella Stoppacciaro; Simona Giglio; Stefano Volinia; Paolo Graziano; Kay Huebner; Andrea Vecchione
Journal:  Cancer Lett       Date:  2010-05-28       Impact factor: 8.679

7.  Oncosuppressor proteins of fragile sites are reduced in cervical cancer.

Authors:  Enrico Giarnieri; Nicola Zanesi; Arianna Bottoni; Mauro Alderisio; Ankica Lukic; Aldo Vecchione; Vincenzo Ziparo; Carlo Maria Croce; Rita Mancini
Journal:  Cancer Lett       Date:  2009-08-22       Impact factor: 8.679

8.  The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOX.

Authors:  Ileana Aderca; Catherine D Moser; Manivannan Veerasamy; Ahmad H Bani-Hani; Ruben Bonilla-Guerrero; Kadra Ahmed; Abdirashid Shire; Sophie C Cazanave; Damian P Montoya; Teresa A Mettler; Lawrence J Burgart; David M Nagorney; Stephen N Thibodeau; Julie M Cunningham; Jin-Ping Lai; Lewis R Roberts
Journal:  J Hepatol       Date:  2008-06-09       Impact factor: 25.083

9.  Molecular alterations in the tumor suppressor gene WWOX in oral leukoplakias.

Authors:  Flávio Juliano Pimenta; Gabriela Tavares Cordeiro; Luiz Gustavo Garcia Santos Pimenta; Michelle Beatriz Viana; Joyce Lopes; Marcus Vinícius Gomez; C Marcelo Aldaz; Luiz De Marco; Ricardo Santiago Gomez
Journal:  Oral Oncol       Date:  2007-12-03       Impact factor: 5.337

10.  Fragile histidine triad protein, WW domain-containing oxidoreductase protein Wwox, and activator protein 2gamma expression levels correlate with basal phenotype in breast cancer.

Authors:  Gulnur Guler; Kay Huebner; Cigdem Himmetoglu; Rafael E Jimenez; Stefan Costinean; Stefano Volinia; Robert T Pilarski; Mutlu Hayran; Charles L Shapiro
Journal:  Cancer       Date:  2009-02-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.